DMEK (Descemet membrane endothelial keratoplasty) is a type of partial corneal transplant that replaces only the innermost layer of the cornea, a tissue just a few cells thick. It is now the most common corneal transplant procedure in the United States, with over 18,000 surgeries performed in 2024 alone. Unlike older transplant techniques that replace the full thickness of the cornea, DMEK swaps out only the damaged layer, leading to faster recovery and better vision outcomes.
What DMEK Actually Replaces
Your cornea has several layers. The outermost layers handle protection and focusing light, while the innermost layer, called the endothelium, works like a pump to keep the cornea clear by pulling excess fluid out. This endothelial layer sits on a thin membrane called Descemet’s membrane. In DMEK, the surgeon removes the patient’s damaged endothelium and Descemet’s membrane, then replaces them with a healthy donor version of those same two layers.
Because the transplanted tissue is so thin, it creates an almost perfect anatomical match. There’s no added stromal (middle-layer) tissue to distort vision, which is the key advantage over older partial transplant techniques. The donor graft essentially disappears into the architecture of your existing cornea.
Who Needs DMEK
The most common reason for DMEK is Fuchs’ endothelial corneal dystrophy, a condition where the endothelial cells gradually die off and the cornea swells with fluid, causing blurry or hazy vision. A preoperative visual acuity worse than 20/40 is generally considered the threshold for recommending surgery, though the decision also factors in corneal thickness and imaging findings. The trend in recent years has been to operate earlier rather than later, since patients who go into surgery with better baseline vision tend to achieve better results at one year.
DMEK can also treat other causes of endothelial failure, including a condition called bullous keratopathy, which sometimes develops after cataract surgery or other eye procedures. However, patients whose condition is something other than Fuchs’ dystrophy carry a somewhat higher risk of complications.
What Makes DMEK Difficult
Certain eye conditions make DMEK technically challenging or unsuitable. The donor tissue needs to unfold properly inside the eye’s front chamber, and anything that disrupts that space can cause problems. Scar tissue connecting the iris to the cornea (called iris synechiae), an incomplete iris, or the presence of a glaucoma drainage tube can all interfere with graft positioning. Patients with these issues may be steered toward a different transplant technique.
How DMEK Compares to Other Transplants
Three main transplant approaches exist for endothelial disease: full-thickness penetrating keratoplasty (PK), DSAEK (which replaces the endothelium along with a thin slice of the middle corneal layer), and DMEK. A ten-year study comparing all three found meaningful differences in both recovery speed and long-term vision.
DMEK patients reached good functional vision (6/12 Snellen, roughly equivalent to 20/40) in a median of about 8 months. DSAEK patients took around 12 months to hit the same mark, and full-thickness transplant patients needed nearly 38 months. By the five-year mark, 93% of DMEK patients had achieved that level of vision, compared to 83% for DSAEK and 63% for full-thickness transplants. At ten years, DMEK’s number climbed to 99%.
Rejection rates also favor DMEK. Over ten years, 10% of DMEK grafts experienced a rejection episode, compared to 19% for DSAEK and 13% for full-thickness transplants. DMEK also produces minimal astigmatism because no sutures pass through the corneal surface, a significant advantage over older techniques that can leave patients dependent on rigid contact lenses or glasses with complex prescriptions.
The Procedure and Recovery
DMEK is typically performed under local anesthesia as an outpatient procedure. The surgeon makes a small incision, removes the diseased endothelium, and inserts the donor tissue, which naturally curls into a scroll. The graft is then unrolled and positioned against the back surface of the cornea. An air bubble is injected underneath to press the tissue into place while it adheres.
After surgery, you’ll need to spend time lying face-up so the air bubble holds the graft against the cornea. Protocols vary between surgeons. Some require one day of supine positioning, others recommend up to five days. Vision improves gradually over weeks to months as the new endothelial cells begin pumping fluid out of the cornea and the swelling clears.
Graft Detachment and Rebubbling
The most common complication specific to DMEK is partial detachment of the donor tissue. In one study using a standardized protocol, about 23% of grafts developed small, self-resolving partial detachments that didn’t require any additional treatment. Only 3.4% needed a “rebubbling” procedure, where the surgeon injects another air bubble to reattach the graft, typically around two to three weeks after the original surgery. Rebubbling is a brief, minor procedure, but eyes that require it do lose more endothelial cells over time and have somewhat lower five-year graft survival (83%) compared to eyes where the graft attached fully on the first attempt (98%).
Long-Term Graft Survival
Five-year graft survival rates for DMEK range from 83% to 96% across published studies, with most reporting around 88% to 90%. A study of 107 consecutive surgeries found an 88% survival probability at five years, with grafts performed specifically for Fuchs’ dystrophy faring slightly better at 89%. These numbers mean the vast majority of patients will still have a functioning graft years after surgery, though a small percentage will need a repeat transplant due to gradual cell loss or late failure.
Surgeon-Prepared vs. Pre-loaded Tissue
Traditionally, the surgeon peels the donor tissue from the donor cornea in the operating room. More recently, eye banks have started offering tissue that arrives pre-stripped or even pre-loaded into an insertion device, ready to implant. This saves time in the operating room, reduces the risk of tissue damage during preparation, and allows the eye bank to verify tissue quality before shipping.
However, the tradeoff isn’t straightforward. One comparative study found that rebubbling rates were significantly higher with pre-loaded tissue (48%) and pre-stripped tissue (40%) compared to surgeon-stripped tissue (15%). This likely reflects the extra handling and storage time the tissue undergoes before it reaches the eye. As preparation techniques continue to improve, these numbers may shift, but for now the choice between surgeon-prepared and eye bank-prepared tissue involves balancing convenience against detachment risk.